Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -2.13EBITDA per Share
VS
Market
Sector
Industry
History
$ 1.85Close
$ 0.41 - $ 2.18 52-Week Range
Ticker Information
Ticker
ALXOCompany Name
ALX ONCOLOGY HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALX ONCOLOGY HOLDINGS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALXO - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -114.05M | $ -2.13 | 1 | 53.45M |
| 3/31/2025 | $ -127.45M | $ -2.39 | 1 | 53.36M |
| 12/31/2024 | $ -132.25M | $ -2.53 | 1 | 52.17M |
| 9/30/2024 | $ -148.58M | $ -2.82 | 1 | 52.69M |
| 6/30/2024 | $ -168.93M | $ -3.26 | 1 | 51.83M |
| 3/31/2024 | $ -163.76M | $ -3.27 | 1 | 50.12M |
| 12/31/2023 | $ -158.4M | $ -3.68 | 1 | 42.99M |
| 9/30/2023 | $ -144.09M | $ -3.5 | 1 | 41.15M |
| 6/30/2023 | $ -128.93M | $ -3.15 | 1 | 40.88M |
| 3/31/2023 | $ -128.19M | $ -3.14 | 1 | 40.86M |
Key Performance Insights, Last 5 Years
- ALX ONCOLOGY HOLDINGS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
- Over the past 5 years, ALX ONCOLOGY HOLDINGS INC's average EBITDAPS has been $ -2.63.
- The median EBITDAPS for ALX ONCOLOGY HOLDINGS INC during this period was $ -2.71
- ALX ONCOLOGY HOLDINGS INC reached its highest EBITDAPS over the past 5 years at $ -1.34.
- The lowest EBITDAPS recorded by ALX ONCOLOGY HOLDINGS INC in the same timeframe $ -3.68
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ALX ONCOLOGY HOLDINGS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 29.66M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ] ALXO - EBITDA per Share, Last 5 years
$ -3.68
Minimum
Dec 31, 2023
$ -1.34
Maximum
Mar 31, 2021
$ -2.63
Average
$ -2.71
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |